Hao Chi
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Zhijia Xia (16 shared papers)Gang Tian (17 shared papers)Gaoge Peng (15 shared papers)Guanhu Yang (35 shared papers)Songyun Zhao (11 shared papers)Jinhao Zhang (14 shared papers)Xixi Xie (11 shared papers)Lai Wei Jiang (22 shared papers)
- Journals
- Frontiers in Immunology (26 papers)Frontiers in Neurology (5 papers)Frontiers in Pharmacology (5 papers)Aging (4 papers)Frontiers in Genetics (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hao Chi
108 papers receiving 2.9k citations
Hao Chi's Hit Papers
Peers
Comparison fields: 5 of 72
- Hepatology 180
- Oncology 373
- Otorhinolaryngology 76
- Cancer Research 135
- Pulmonary and Respiratory Medicine 301
Countries citing papers authored by Hao Chi
This map shows the geographic impact of Hao Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Chi more than expected).
Fields of papers citing papers by Hao Chi
This network shows the impact of papers produced by Hao Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Chi. The network helps show where Hao Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 145 | |
| 2 | 2023 | 112 | |
| 3 | 2022 | 109 | |
| 4 | 2022 | 89 | |
| 5 | 2023 | 73 | |
| 6 | 2024 | 73 | |
| 7 | 2023 | 68 | |
| 8 | 2023 | 68 | |
| 9 | 2023 | 64 | |
| 10 | 2023 | 63 | |
| 11 | 2023 | 63 | |
| 12 | 2022 | 60 | |
| 13 | 2022 | 59 | |
| 14 | 2022 | 56 | |
| 15 | 2023 | 53 | |
| 16 | 2023 | 51 | |
| 17 | 2023 | 50 | |
| 18 | 2022 | 48 | |
| 19 | 2023 | 48 | |
| 20 | 2023 | 47 |
About Hao Chi
Hao Chi is a scholar working on Hepatology, Oncology, Cancer Research, Otorhinolaryngology and Complementary and alternative medicine, having authored 109 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Head and Neck Cancer Studies (5 papers), Extracellular vesicles in disease (5 papers), Acupuncture Treatment Research Studies (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related molecular mechanisms research (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hepatology (180 citations), Oncology (373 citations), Otorhinolaryngology (76 citations), Cancer Research (135 citations) and Pulmonary and Respiratory Medicine (301 citations). Hao Chi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhijia Xia, Gang Tian, Gaoge Peng, Guanhu Yang, Songyun Zhao, Jinhao Zhang, Xixi Xie, Lai Wei Jiang, Ke Xu and Jinyan Yang. Their work appears in journals such as Frontiers in Immunology, Frontiers in Neurology, Frontiers in Pharmacology, Aging and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.